Previous 10 | Next 10 |
Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for cancer and other serious diseases, today announced that Aviad Pato, Ph.D., Head of Immunology Research, presented data on two nicotinamide (NAM)-enabled NK cell therapies, GDA-501 and GDA-301, a...
Today, we revisit an intriguing Israeli-based biotech concern called Gamida Cell for the first time since March. The shares have seen declines in 2021, like most small biotechs this year, even as the company continues to march to its first FDA approval. Time to buy the dip? A full...
Company recently filed an IND application for GDA-201; FDA placed the application on Clinical Hold pending modifications to donor eligibility procedures and sterility assay qualification Today’s presentations to highlight expanded NAM-enabled NK cell therapy platf...
Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for cancer and other serious diseases, today announced that data evaluating the company’s NAM-enabled NK cell platform will be presented at the Society for Immunotherapy of Cancer’s 36...
Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that it will host a virtual event detailing the company’s proprietary NAM-enabled natural killer (NK) cell therapy pipeline on Tuesda...
Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that company management will present its corporate highlights at the following virtual investor conferences in September: H.C. Wainwri...
Image source: The Motley Fool. Gamida Cell Ltd. (NASDAQ: GMDA) Q2 2021 Earnings Call Aug 11, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Gamida Cell Ltd. (GMDA) Q2 2021 Earnings Call Transcript
Gamida Cell Ltd (GMDA) Q2 2021 Earnings Conference Call August 11, 2021, 08:00 ET Company Participants Joshua Hamermesh - Chief Business Officer Julian Adams - CEO & Director Ronit Simantov - Chief Medical Officer Michele Korfin - Chief Operating & Chief Commercial Officer Shai Lankry...
The following slide deck was published by Gamida Cell Ltd. in conjunction with their 2021 Q2 earnings call. For further details see: Gamida Cell Ltd. 2021 Q2 - Results - Earnings Call Presentation
BLA submission for omidubicel, a potentially life-saving treatment for patients with blood cancers in need of stem cell transplant, expected in fourth quarter of 2021 Commercial readiness activities underway to support potential launch in 2022 Phase 1/2 clini...
News, Short Squeeze, Breakout and More Instantly...
Gamida Cell Ltd. Company Name:
GMDA Stock Symbol:
NASDAQ Market:
CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney d...
2024-04-03 06:21:00 ET How to Analyze Different Penny Stocks Sectors to Make Money Investing in penny stocks offers an accessible entry point for individuals aiming to participate in the stock market with a lower initial investment. Analyzing different sectors within the realm of penn...
A look at the top 10 most actives in the United States Trio Petroleum Corp. (TPET) rose 43.8% to $0.1485 on volume of 202,621,744 shares Nikola Corporation (NKLA) fell 5.5% to $0.9736 on volume of 187,304,976 shares C3is Inc. (CISS) rose 13.3% to $0.0409 on volume of 136,767,990 shares ...